Be the first person to write a business review for Becton, Dickinson and Company

Benco Dental, the largest privately owned, full-service dental distributor in the United States, has remained in the family since 1930—a family that now includes our more than 30,000 customers and 1,200 associates in 40 states. It’s our mission to deliver success smile after smile. We provide more supply and equipment options than any other full-service distributor, an offering enhanced by a comprehensive suite of services, including office design, equipment repair, practice coaching, financing and project management, wealth management and dental-specific technology solutions. These services are supported by over 340 professionally trained sales representatives and 265 factory-trained service technicians.During Benco Dental’s 80-year history, the company has grown from a single-room office in Wilkes-Barre, PA into the nation’s fastest growing dental distributor with 50 regional showroom locations and four distribution centers. In 2010, Benco Dental opened North America’s largest dental equipment showroom as part of a new corporate headquarters. CenterPoint, the 272,000-square-foot facility built to LEED Silver specifications, is home to 25 fully functional operatories and 14 operational digital X-ray units. It also contains a design concept suite, specialty displays, a handpiece cutting exhibit, sterilization models, and a state-of-the-art training and technology center. CenterPoint is the only place where dentists can come to test drive equipment prior to a purchase.

Bioject Medical Technologies Inc., together with its subsidiaries, develops, manufactures, and distributes needle-free injection therapy systems (NFITS) in the United States and internationally. The company’s NFITS work by forcing liquid medication at high speed through a tiny orifice held against the skin. It offers Biojector 2000, a refinement of jet injection technology that enables healthcare professionals to deliver measured variable doses of medication through the skin, either intramuscularly or subcutaneously without a needle; and drug reconstitution system that allows the transfer of diluents to reconstitute powdered medications into liquid form and withdrawal of liquid medication into a syringe without the use of a needle. Bioject Medical Technologies also offers Vitajet, which is composed of two components, a portable injector unit and a disposable syringe; and ZetaJet, a compact and spring-powered injection device intended to deliver vaccines and injectable medications either subcutaneously or intramuscularly. In addition, the company is developing Iject needle-free injection system, a single prefilled disposable injector for self-injection; Jupiter Jet, a pistol-shaped, or streamlined ergonomic gas-powered injection device for patient and professional use; and pre-filled Biojector syringes. It has a strategic alliance with MPI Research. Bioject Medical Technologies Inc. was founded in 1985 and is based in Tualatin, Oregon.

BIOLASE Technology, Inc. was founded in 1984 and is headquartered in Irvine, California. BIOLASE Technology, Inc., a medical technology company, develops, manufactures, and markets lasers and related products and services focused on technologies for applications and procedures in dentistry and medicine. Its principal products are dental laser systems that allow general dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. BioLase Technology offers two categories of laser system products comprising Waterlase family of products and Diode family of products. The Waterlase systems use a combination of water and laser to perform dental procedures for cutting soft and hard tissue plus bone. Its Waterlase systems include Waterlase MD and Waterlase C100 All-Tissue Dental Laser systems. The Diode systems use a semiconductor diode laser to perform soft tissue, hygiene, and cosmetic procedures, including teeth whitening, as well as pain management therapy. Its Diode systems consist of the ezlase, iLase, and Diolase 10 systems. BioLase Technology also provides related accessories and disposable products for its laser systems, which include disposable laser tips, flexible fibers, hand pieces, and tooth whitening gel kits. BIOLASE Technology, Inc. sells its products through direct sales force and a network of independent distributors in the United States and internationally. BioLase Technology was formerly known as Societe Endo Technic, SA and changed its name to BIOLASE Technology, Inc. in 1994.

Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California. Biomerica, Inc. develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. Its diagnostic test kits are used to analyze blood or urine from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens, or other substances, which might exist in the human body in small concentrations. The company’s clinical laboratory diagnostic products include tests for bone and anemia conditions, gastrointestinal diseases, food intolerance, diabetes, and others. It offers its medical diagnostic products primarily to hospital and clinical laboratories, medical research institutions, medical schools, pharmaceutical companies, chain drugstores, wholesalers, and physicians’ offices worldwide. The company was formerly known as NMS Pharmaceuticals, Inc. and changed its name to Biomerica, Inc. in November 1987.

BioMimetic (NASDAQ: BMTI) is a biotechnology company developing orthopedic surgical devices that deliver purified recombinant human platelet-derived growth factor (rhPDGF-BB) to promote tissue healing and regeneration. rhPDGF-BB is a synthetic form of PDGF, one of the body's principal agents to stimulate and direct healing and regeneration. The mechanism of action of PDGF suggests it may be effective in a broad array of musculoskeletal applications, including the repair of bone, ligament, tendon and cartilage. Through the commercialization of this technology, BioMimetic seeks to become the leading company in the field of orthopedic regenerative medicine. While on staff at Harvard beginning in the mid 1980s, Dr. Samuel Lynch, BioMimetic's president, CEO and founder, conducted research on the role of PDGF in tissue repair and regeneration. These efforts generated a foundation of scientific knowledge and intellectual property from which BioMimetic Therapeutics is now based.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.